Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cytek Biosciences Inc (CTKB)

Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 758,779
  • Shares Outstanding, K 130,824
  • Annual Sales, $ 193,020 K
  • Annual Income, $ -12,150 K
  • 60-Month Beta 1.37
  • Price/Sales 4.01
  • Price/Cash Flow 236.29
  • Price/Book 2.06
Trade CTKB with:

Options Overview Details

View History
  • Implied Volatility 268.34% ( +77.14%)
  • Historical Volatility 42.46%
  • IV Percentile 99%
  • IV Rank 100.00%
  • IV High 268.34% on 04/22/24
  • IV Low 1.84% on 10/12/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 34
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 338
  • Open Int (30-Day) 1,638

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.04
  • Number of Estimates 2
  • High Estimate -0.03
  • Low Estimate -0.05
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.70 +4.04%
on 04/22/24
7.02 -15.60%
on 04/09/24
-0.54 (-8.42%)
since 03/22/24
3-Month
5.70 +4.04%
on 04/22/24
9.33 -36.48%
on 03/04/24
-2.84 (-32.36%)
since 01/23/24
52-Week
3.80 +55.92%
on 11/08/23
12.31 -51.87%
on 05/04/23
-4.18 (-41.34%)
since 04/21/23

Most Recent Stories

More News
Why Shares of Cytek Biosciences Dropped This Week

Cytek grew revenue and losses in the first quarter.

CTKB : 5.91 (+1.90%)
Cytek Biosciences, Inc. (CTKB) Reports Break-Even Earnings for Q1

Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of -100% and 19.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CTKB : 5.91 (+1.90%)
ETON : 3.34 (+2.77%)
Cytek Biosciences, Inc. (CTKB) Soars 13.4%: Is Further Upside Left in the Stock?

Cytek Biosciences, Inc. (CTKB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

CTKB : 5.91 (+1.90%)
VRTX : 404.19 (+1.07%)
Cytek Biosciences Set to Join S&P SmallCap 600

/PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening...

SPGI : 412.98 (-0.95%)
CTKB : 5.91 (+1.90%)
CSII : 20.00 (+0.15%)
ABT : 107.70 (+0.59%)
Encompass Health (EHC) Up 32% in 6 Months: More Room to Run?

Encompass Health (EHC) is well-poised for growth on the back of growing facility count within its Inpatient Rehabilitation segment and sound liquidity position.

SYK : 332.83 (+1.57%)
HSIC : 72.69 (+0.90%)
EHC : 81.93 (+1.99%)
CTKB : 5.91 (+1.90%)
Here's Why Cytek Biosciences, Inc. (CTKB) is Poised for a Turnaround After Losing -16.6% in 4 Weeks

Cytek Biosciences, Inc. (CTKB) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts...

CTKB : 5.91 (+1.90%)
Here's Why You Should Retain HCA Healthcare (HCA) Stock Now

HCA Healthcare (HCA) remains well-poised for growth on the back of improved revenues, a well-diversified healthcare portfolio and sufficient cash-generating abilities.

HCA : 318.51 (+2.64%)
ADUS : 92.65 (-0.90%)
LNTH : 65.06 (+3.16%)
CTKB : 5.91 (+1.90%)
Cytek Biosciences, Inc. (CTKB) Q4 Earnings Top Estimates

Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

CTKB : 5.91 (+1.90%)
ANAB : 20.31 (+3.31%)
Cytek Biosciences, Inc. (CTKB) Q3 Earnings Surpass Estimates

Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 100% and 6.64%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

CTKB : 5.91 (+1.90%)
LVTX : 3.00 (+5.26%)
G1 Therapeutics (GTHX) Reports Q3 Loss, Tops Revenue Estimates

G1 Therapeutics (GTHX) delivered earnings and revenue surprises of 7.81% and 4.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

GTHX : 4.19 (+2.20%)
CTKB : 5.91 (+1.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Cytek Biosciences Inc provides cell analysis solutions. The company developed high-resolution, high-content and high-sensitivity cell analysis technology called Full Spectrum Profiling. Cytek Biosciences Inc is based in FREMONT, Calif.

See More

Key Turning Points

3rd Resistance Point 6.09
2nd Resistance Point 5.99
1st Resistance Point 5.89
Last Price 5.91
1st Support Level 5.70
2nd Support Level 5.60
3rd Support Level 5.51

See More

52-Week High 12.31
Fibonacci 61.8% 9.06
Fibonacci 50% 8.06
Fibonacci 38.2% 7.05
Last Price 5.91
52-Week Low 3.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar